10th International Workshop on HIV Paediatrics – second reports
20–21 July 2018, Amsterdam
The 10th International Workshop on HIV Paediatrics was held 20–21 July 2018 in Amsterdam, just before the AIDS 2018 conference..
The paediatrics workshop is the only HIV meeting devoted to research in prevention and treatment for infants, children and adolescents. Since 2009, this workshop has preceded the IAS conference and dual submissions to both meetings are permitted.
This year’s meeting included: pharmacokinetic and early safety and efficacy data for dolutegravir in children aged four weeks to six years; the first public presentation from the Tsepamo study of a potential safety signal with dolutegravir from conception; first data from the ODYSSEY trial; data on tenofovir alafenamide in the bictegravir-based fixed dose combination for six to twelve year olds; and much more.
The abstracts as well as slides of the presentations and webcasts are posted online when consent has been provided.
The HTB report in this issue is: